Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Mark E. Bensink"'
Autor:
Robert Urman, Nicole Princic, Fiston Vuvu, Leah B. Patel, Sam Oh, David Chandler, Nada Hindiyeh, Mark E. Bensink
Publikováno v:
Pain and Therapy, Vol 13, Iss 5, Pp 1299-1313 (2024)
Abstract Introduction Erenumab-aooe is approved for the preventive treatment of migraine in adults. Recent publications have evaluated migraine medication use during the 6 months after starting erenumab, but longer-term follow-up data are limited. Th
Externí odkaz:
https://doaj.org/article/37ee4c166c2a400f81c6ef001ee91aca
Autor:
Ani C. Khodavirdi, Jasjit K. Multani, Sam S. Oh, Fiston Vuvu, Mark E. Bensink, Karen M. Stockl, Kevin Hawkins, Chia-Chun Chiang, A. Laine Green, Stewart J. Tepper
Publikováno v:
Frontiers in Neurology, Vol 15 (2024)
IntroductionMigraine is a debilitating neurological disorder, with a wide range of symptoms and disease burden, underscoring the heterogeneity of patients’ disease characteristics and treatment needs. To characterize the profile of migraine patient
Externí odkaz:
https://doaj.org/article/40ba0f75cd51477882b9369731b68aae
Autor:
Zifan Zhou, Robert Urman, Karminder Gill, Andrew S. Park, Fiston Vuvu, Leah B. Patel, Jingsong Lu, Rolin L. Wade, Lindsay Frerichs, Mark E. Bensink
Publikováno v:
The Journal of Headache and Pain, Vol 24, Iss 1, Pp 1-12 (2023)
Abstract Background New acute and preventive migraine medications are available, but data on current treatment patterns are limited. This study describes migraine treatment patterns among patients initiating novel acute migraine specific medications
Externí odkaz:
https://doaj.org/article/aaaf905c823a46b999355dfc1338b397
Autor:
Mark E. Bensink, Deborah Goldschmidt, Zheng-Yi Zhou, Kaijun Wang, Richard Lieblich, Martin C. Bunke
Publikováno v:
Kidney Medicine, Vol 6, Iss 2, Pp 100759- (2024)
Rationale & Objective: This study describes the epidemiology, characteristics, and outcomes of patients with immunoglobulin A nephropathy (IgAN)-attributed kidney failure in the US Renal Data System (USRDS) from 2008 to 2018, including health care re
Externí odkaz:
https://doaj.org/article/314bdeb7d38c4f71a0f7f4fe3d5f0fc6
Autor:
Mark E. Bensink, Deborah Goldschmidt, Zheng-Yi Zhou, Kaijun Wang, Richard Lieblich, C. Martin Bunke
Publikováno v:
Kidney Medicine, Vol 6, Iss 2, Pp 100760- (2024)
Rationale & Objective: This study describes the epidemiology, characteristics, and clinical outcomes of patients with focal segmental glomerulosclerosis (FSGS)-attributed kidney failure in the US Renal Data System (USRDS) during 2008-2018, and health
Externí odkaz:
https://doaj.org/article/4b1ded3784244132af98948074b8a9de
Autor:
Edgar V. Lerma, Mark E. Bensink, Kamlesh M. Thakker, Richard Lieblich, Martin Bunke, Andrew Rava, Kaijun Wang, Michael V. Murphy, David Oliveri, Diana T. Amari, David M.W. Cork, Juan Carlos Q. Velez
Publikováno v:
Kidney Medicine, Vol 5, Iss 9, Pp 100693- (2023)
Rationale & Objective: Among patients with IgA nephropathy (IgAN), proteinuria and decline in kidney function may be associated with increased economic burden. This study aimed to provide current information on the epidemiology and economic burden of
Externí odkaz:
https://doaj.org/article/e33410ce7fec43b78211b11885be8679
Publikováno v:
Journal of Patient-Reported Outcomes, Vol 2, Iss 1, Pp 1-17 (2018)
Abstract Background We developed the Nausea/Vomiting Symptom Assessment (NVSA©) patient-reported outcome (PRO) instrument to capture patients’ experience with nausea and vomiting while on calcimimetic therapy to treat secondary hyperparathyroidism
Externí odkaz:
https://doaj.org/article/4142ab1083414c2da44ae6a65f49828f
Autor:
Kenar D. Jhaveri, Mark E. Bensink, Martin Bunke, Jonathon A. Briggs, David M. W. Cork, Anushya Jeyabalan
Publikováno v:
PharmacoEconomics - Open.
Autor:
Shuling, Li, Jiannong, Liu, Charles, Bowers, Tamer A F S, Garawin, Christopher, Kim, Mark E, Bensink, David B, Chandler
Publikováno v:
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 28(1)
Limited information is available regarding elderly patients experiencing febrile neutropenia (FN). This study evaluated FN-related care among elderly cancer patients who received high/intermediate FN-risk chemotherapy and experienced ≥ 1 FN episode
Autor:
Steven M, Brunelli, Scott, Sibbel, Paul J, Dluzniewski, Kerry, Cooper, Mark E, Bensink, Brian D, Bradbury
Publikováno v:
Pharmacoepidemiology and drug safety. 25(11)
Missed in-center hemodialysis treatments (MHT) are a general indicator of health status in hemodialysis patients. This analysis was conducted to estimate the association between cinacalcet use and MHT rate.We studied patients receiving hemodialysis a